Institutional investors purchased a net $841.6 thousand shares of BSTC during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 66.35% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ABDIEL CAPITAL ADVISORS LLC Bought 459.7 Thousand shares of Biospecifics Technologies...
RENAISSANCE TECHNOLOGIES LLC Bought 60.7 Thousand shares of Biospecifics Technologies...